Jamaican 🩺 🇯🇲 in Boston📍 Liver @massgenbrigham @BrighamGI | MPH @harvardchanSPH
Joined March 2020
- Tweets1.1K
- Following666
- Followers722
- Likes2.5K
🏆 Editor's Pick of the Month #ACGCRJ
Kwashiorkor Mimicking Portal Hypertensive Ascites After Bariatric Surgery
tinyurl.com/3z3wrkzh
Not all high-SAAG ascites is portal hypertension: kwashiorkor after bariatric surgery can be a convincing mimic.
Brittany Bromfield retweeted
Exciting time in MASLD, lots of emerging compounds.
One to know => survodutide
➡️ GLPRA/Glucagon agonist
➡️ unlike GLP, liver has glucagon receptors so survodutide acts directly on the liver
➡️ SYNCHRONIZE-MASLD 2026
- MASLD pts defined by MRI (~90%) likely with F0-2
- survodutide met co-primary endpoints
1. 84% had =>30% reduction in liver fat
Brittany Bromfield retweeted
Congratulations to our incredible Program Director, Dr. Molly Perencevich, on receiving the @MassGenBrigham Graduate Medical Education Outstanding Program Director Award, selected from among all training programs throughout the MGB system🏆
Thank you, Molly, for your unwavering dedication to fellow education, mentorship, and exceptional leadership. So well deserved! 👏🎉
Brittany Bromfield retweeted
Welcome! We're thrilled for you to be part of the AGA journals family and contribute to @AGA_CGH!
Brittany Bromfield retweeted
Congrats to our 11 new editorial fellows! They'll work closely with our journals editors and staff to gain hands-on editorial experience and mentorship. @DrYichenWang @JA_Lowell_MDPhD @brittybb @CMcKAguirreDVM @BibekSahaMD ow.ly/qcmb50ZflEU
Excited to start as the CGH Editorial Fellow for the AGA on July 1! Looking forward to learning from the incredible editorial team and contributing to CGH this year. @AGA_CGH @AmerGastroAssn
#GITwitter #MedTwitter #Gastroenterology #Hepatology
Yesterday I graduated from
@BrighamGI fellowship, and today I get to celebrate my first @NEJM publication. Feeling very grateful, very lucky, and very excited for what’s next. 🎓📄✨
Brittany Bromfield retweeted
Andres Duarte-Rojo, MD, is a part of a team leading Northwestern Medicine's efforts to enhance survival of patients who are preparing for liver transplantation through a personalized at-home program that assesses mobility, exercise, diet and more. This program prepares patients for transplantation and aims to reduce post-transplant complications and hospital admissions. Read the full article: breakthroughsforphysicians.n…
Graduated from the Harvard Chan School of Public Health
@HarvardChanSPH
today! Also found out I’ll be the next
@AGA_CGH
editorial fellow 😀 feeling so incredibly excited for this opportunity 🧬 @BrighamGI
Brittany Bromfield retweeted
Alcohol use disorder accounts for 5% of deaths worldwide annually, and there is an urgent need for new treatments.
A new study found that GLP-1 reduces heavy drinking days in treatment seeking people with alcohol use disorder and obesity: spkl.io/6012AfU04
ALT Figure showing effects of once-weekly semaglutide compared with placebo on\nreduction in heavy drinking days and total alcohol consumption. Changes from baseline (week 0) to follow-up (week 26) are shown for mean percent heavy drinking days in the last 30 days (A), and mean alcohol (g) consumed during the past 30 days (B), in participants randomly assigned to semaglutide 2\u00B74 mg (n=54) or placebo (n=54). Participant level changes by treatment group are in appendix 1 (p 15). SEM=standard error of the mean. Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.